Early onset neutropenia after mycophenolate mofetil in systemic sclerosis

Rheumatology International

Volumn 29, Issue 12, 2009, Pages 1529-1530

  Cuomo, Giovanna ^a   Abignano, Giuseppina ^a   Valentini, Gabriele ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DOMPERIDONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTON PUMP INHIBITOR; STEROID;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; NEUTROPENIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MIDDLE AGED; MYCOPHENOLIC ACID; NEUTROPENIA; SCLERODERMA, SYSTEMIC;

EID: 69049091867     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0879-6     Document Type: Letter

References (10)

1. G Ciancio J Miller TA Gonwa 2005 Review of major clinical trial with mycophenolate mofetil in renal transplantation Transplantation 80 (2 Suppl) S191 S200 10.1097/01.tp.0000187035.22298.ba
2. JA Kobashigawa BM Meiser 2005 Review of major clinical trials with mycophenolate mofetil in cardiac transplantation Transplantation 80 (2 Suppl) S235 S243 10.1097/01.tp.0000186383.22264.b3
3. TM Chan FK Li CS Tang, et al. 2000 Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 1156 1162 10.1056/NEJM200010193431604
4. EM Ginzler MA Dooley C Aranow, et al. 2005 Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 353 2219 2228 10.1056/NEJMoa043731
5. H Shimizu M Takahashi S Takeda, et al. 2004 Mycophenolate mofetil prevents transplant ateriosclerosis by direct inhibition of vascular smooth muscle cell proliferation Transplantation 77 1661 1667 10.1097/01.TP.0000127592. 13707.B6
6. DJ Miljkovic I Cvetkovic 2003 STOSIC-GRUJICIC, TRAJKOVIC V: mycophenolate acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts Clin Exp Immunol 132 239 246 10.1046/j.1365-2249.2003.02140.x
7. SN Liossis A Bounas AP Andonopoulos 2006 Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease Rheumatology 45 1005 1008 10.1093/rheumatology/kei211
8. SI Nihtyanova GM Brough CM Black CP Denton 2007 Mycophenolate mofetil in diffuse cutaneous systemic sclerosis-a retrospective analysis Rheumatology 46 442 445 10.1093/rheumatology/kel244
9. M Vanthuyne D Blockmans R Westhovens, et al. 2007 A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis Clin Exp Rheumatol 25 287 292
10. F Nogueras MD Espinosa A Mansilia, et al. 2005 Mycophenolate mofetil-induce neutropania in liver transplantation Transplant Proc 37 1509 1511 10.1016/j.transproceed.2005.02.038